Cargando…
The Serum Metabolic Biomarkers in Early Diagnosis and Risk Stratification of Acute Coronary Syndrome
Despite advances in the treatment of coronary diseases, acute coronary syndrome (ACS) remains the leading cause of death worldwide. ACS is associated with metabolic abnormalities of lipid oxidation stress. In this study, based on liquid chromatograph mass spectrometry technique, we conducted the met...
Autores principales: | Jiang, Huali, Jiang, Hualong, Zhang, Jian, Chen, Weijie, Luo, Changyou, Li, Heng, Hau, William, Chen, Benfa, Wang, Shanhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386197/ https://www.ncbi.nlm.nih.gov/pubmed/32792969 http://dx.doi.org/10.3389/fphys.2020.00776 |
Ejemplares similares
-
Application of Metabolomics to Identify Potential Biomarkers for the Early Diagnosis of Coronary Heart Disease
por: Jiang, Huali, et al.
Publicado: (2021) -
The Evaluation of Serum Biomarkers for Non-small Cell Lung Cancer (NSCLC) Diagnosis
por: Fang, Rui, et al.
Publicado: (2018) -
Serum Exosomal MicroRNA-21, MicroRNA-126, and PTEN Are Novel Biomarkers for Diagnosis of Acute Coronary Syndrome
por: Ling, Hao, et al.
Publicado: (2020) -
Serum Metabolomic Profiling to Reveal Potential Biomarkers for the Diagnosis of Fatty Liver Hemorrhagic Syndrome in Laying Hens
por: Guo, Lianying, et al.
Publicado: (2021) -
Insights into lipid metabolism and immune-inflammatory responses in the pathogenesis of coronary artery ectasia
por: Jiang, Li, et al.
Publicado: (2023)